Seamus Fernandez
Stock Analyst at Guggenheim
(4.90)
# 255
Out of 4,429 analysts
402
Total ratings
61.9%
Success rate
25.2%
Average return
Main Sectors:
Stocks Rated by Seamus Fernandez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $143 | $96.79 | +47.74% | 13 | Jun 15, 2026 | |
| MBX MBX Biosciences | Reiterated: Buy | $88 | $43.03 | +104.51% | 14 | Jun 15, 2026 | |
| GENB Generate Biomedicines | Maintained: Buy | $30 | $14.49 | +107.04% | 2 | Jun 15, 2026 | |
| SEPN Septerna | Initiated Coverage: Buy | $52 | $36.17 | +43.77% | 1 | Jun 11, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $72 | $54.00 | +33.33% | 48 | Jun 5, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,500p | $13,234.00 | +24.68% | 19 | Jun 3, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | $116 | $51.44 | +125.51% | 12 | Jun 3, 2026 | |
| IVA Inventiva | Reiterated: Buy | $11 | $3.57 | +208.12% | 6 | May 27, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintained: Buy | $35 | $26.21 | +33.54% | 13 | May 26, 2026 | |
| MLYS Mineralys Therapeutics | Maintained: Buy | $48 | $24.63 | +94.88% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.53 | - | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.50 | +166.67% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $15.67 | +91.45% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $44.51 | +214.54% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,163 → $1,235 | $1,098.57 | +12.42% | 61 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $6.68 | +274.25% | 4 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $90.38 | +77.03% | 11 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $34 | $12.00 | +183.33% | 5 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $42.38 | - | 12 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €110.00 → €101.00 | $74.14 | +36.23% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.19 | n/a | 10 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.70 | n/a | 12 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,013 → kr 798.00 | $293.31 | n/a | 4 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.67 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,925.50 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $130 | $113.87 | n/a | 36 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $83 | $18.18 | n/a | 5 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9699 | n/a | 2 | Dec 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $132.90 | n/a | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $118.30 | n/a | 4 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $147.08 | n/a | 16 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $6.05 | n/a | 1 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.13 | n/a | 2 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $25.21 | n/a | 16 | Sep 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $15.90 | n/a | 1 | Aug 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $6.76 | n/a | 3 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $278.09 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $337.60 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $609.94 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $228.39 | n/a | 2 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $34.16 | n/a | 5 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $32.43 | n/a | 1 | Mar 7, 2016 |
Rhythm Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: $143
Current: $96.79
Upside: +47.74%
MBX Biosciences
Jun 15, 2026
Reiterated: Buy
Price Target: $88
Current: $43.03
Upside: +104.51%
Generate Biomedicines
Jun 15, 2026
Maintained: Buy
Price Target: $30
Current: $14.49
Upside: +107.04%
Septerna
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $36.17
Upside: +43.77%
Bristol-Myers Squibb Company
Jun 5, 2026
Maintained: Buy
Price Target: $72
Current: $54.00
Upside: +33.33%
AstraZeneca PLC
Jun 3, 2026
Maintained: Buy
Price Target: 16,500p
Current: $13,234.00
Upside: +24.68%
Vaxcyte
Jun 3, 2026
Maintained: Buy
Price Target: $116
Current: $51.44
Upside: +125.51%
Inventiva
May 27, 2026
Reiterated: Buy
Price Target: $11
Current: $3.57
Upside: +208.12%
Arcutis Biotherapeutics
May 26, 2026
Maintained: Buy
Price Target: $35
Current: $26.21
Upside: +33.54%
Mineralys Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $48
Current: $24.63
Upside: +94.88%
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $7.53
Upside: -
May 11, 2026
Reiterated: Buy
Price Target: $12
Current: $4.50
Upside: +166.67%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $15.67
Upside: +91.45%
May 7, 2026
Maintained: Buy
Price Target: $140
Current: $44.51
Upside: +214.54%
May 5, 2026
Maintained: Buy
Price Target: $1,163 → $1,235
Current: $1,098.57
Upside: +12.42%
Apr 29, 2026
Reiterated: Buy
Price Target: $27 → $25
Current: $6.68
Upside: +274.25%
Mar 30, 2026
Reiterated: Buy
Price Target: $160
Current: $90.38
Upside: +77.03%
Mar 16, 2026
Maintained: Buy
Price Target: $25 → $34
Current: $12.00
Upside: +183.33%
Dec 9, 2025
Downgraded: Hold
Price Target: n/a
Current: $42.38
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: €110.00 → €101.00
Current: $74.14
Upside: +36.23%
Apr 17, 2025
Downgraded: Hold
Price Target: n/a
Current: $43.19
Upside: n/a
Apr 3, 2025
Rated: Hold
Price Target: n/a
Current: $2.70
Upside: n/a
Jan 17, 2025
Maintained: Buy
Price Target: kr 1,013 → kr 798.00
Current: $293.31
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $50.67
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $1,925.50
Upside: n/a
Jan 29, 2024
Maintained: Buy
Price Target: $125 → $130
Current: $113.87
Upside: n/a
Oct 14, 2022
Maintained: Buy
Price Target: $250 → $83
Current: $18.18
Upside: n/a
Dec 15, 2021
Downgraded: Hold
Price Target: n/a
Current: $0.9699
Upside: n/a
Dec 7, 2021
Downgraded: Hold
Price Target: n/a
Current: $132.90
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: n/a
Current: $118.30
Upside: n/a
Oct 8, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $147.08
Upside: n/a
Oct 17, 2017
Initiated Coverage: Buy
Price Target: $13
Current: $6.05
Upside: n/a
Sep 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $4.13
Upside: n/a
Sep 8, 2016
Maintained: Hold
Price Target: $37
Current: $25.21
Upside: n/a
Aug 24, 2016
Reiterated: Buy
Price Target: $108
Current: $15.90
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $52
Current: $6.76
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $278.09
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $337.60
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $609.94
Upside: n/a
Jun 14, 2016
Maintained: Buy
Price Target: $125
Current: $228.39
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $56
Current: $34.16
Upside: n/a
Mar 7, 2016
Downgraded: Hold
Price Target: $4
Current: $32.43
Upside: n/a